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Abstract
Background: Obesity has been reported to be associated with iron deficiency. However, few studies have investigated
iron status in low adiposity. To investigate whether body adiposity was associated with altered hepatic iron status,
we compared liver iron levels and markers involved in inflammation and iron absorption in obese, control, and mildly
calorie restricted mice.
Methods: Seven week old C57BL/6 mice were fed control (10% kcal fat, Control) or high fat (60% kcal fat, HFD) diets, or
reduced amount of control diet to achieve 15% calorie restriction (CR) for 16 weeks. Hepatic non-heme iron content and
ferritin protein level, and hematocrit and hemoglobin levels were determined to assess iron status. Hepatic expression of
Mcp-1 and Tnf-α were measured as hepatic inflammatory markers. Hepatic hepcidin (Hamp) and Bmp6, and duodenal Dmt1,
Dcyt1b, hephaestin (Heph) and ferroportin mRNA levels were measured as factors involved in regulation of iron absorption.
Results: Hepatic non-heme iron and ferritin protein levels were significantly higher in the CR group compared
with the Control group, and significantly lower in the HFD group. These two iron status markers showed
significantly negative correlations with the amount of white adipose tissue (r = -0.689 for hepatic non-heme iron
and r = -0.740 for ferritin). Hepatic Mcp-1 and Tnf-α mRNA levels were significantly lower in the CR compared with
the HFD (74 and 47% lower) and showed significantly negative correlations with hepatic non-heme iron levels
(Mcp-1: r = -0.557, P < 0.05; Tnf-α: r = -0.464, P < 0.05). Hepatic Hamp mRNA levels were lower in the HFD and
higher in the CR groups compared with the Control group, which could be a response to maintain iron
homeostasis. Duodenal Dcyt1b mRNA levels were higher in the CR group compared with the HFD group and
duodenal Heph mRNA levels were higher in the CR group than the Control group.
Conclusion: We showed that body adiposity was inversely correlated with liver iron status. Low inflammation
levels in hepatic milieu and enhanced expression of duodenal oxidoreductases induced by calorie restriction
could have contributed to higher iron status.
Keywords: Hepatic non-heme iron, Mild calorie restriction, Iron absorption, Duodenal iron transporter, Hepcidin,
Body adiposity
Background
Iron deficiency is the most prevalent single nutrient
problem and the most common cause of anemia. More
than two billion people in both developing and industri-
alized countries are anemic due to iron deficiency [1].
Iron deficiency and obesity are often observed together
and obesity has been reported as a possible factor leading
to under-nutrition of iron in recent years [2–8]. Although
the etiology of iron deficiency associated with obesity is
uncertain, many animal and clinical studies have reported
reduced iron storage with obesity. Systemic chronic
inflammation induced by obesity and higher hepcidin
levels have been suggested as a reason for impaired iron
absorption due to inhibition of iron transport across
the basolateral enterocyte membrane by the action of
hepcidin [3, 4, 9].
Hepcidin (Hamp) is the central regulator of iron homeo-
stasis and is mainly released from the liver. When the iron
level is high, iron activates the bone morphogenetic protein
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(BMP) pathway and phosphorylates Smad to increase hep-
cidin expression. Hepcidin binds to ferroportin and induces
its internalization, preventing efflux of iron from enterocyte
to the circulation [10–12]. When the iron level is low, re-
lease of hepcidin from liver decreases [13]. Inflammatory
states can also increase hepcidin expression. Lipopolysac-
charide (LPS)-treatment increased Hamp mRNA levels in
primary hepatocyte, Hep3B, and rat liver tissue [14, 15].
Obese patients with upregulated levels of serum C-reactive
protein (CRP) and interleukin (IL)-6 had higher serum hep-
cidin levels [4, 5, 16]. Therefore, increased hepcidin expres-
sion mediated by inflammatory response has been
suggested as one of the mechanisms for obesity related low
iron level [11, 17, 18]. On the other hand, Sonnweber et al.
[19] reported that iron deficiency observed with obesity
was independent of hepcidin expression. Rather, it was
suggested that decreased expression of iron absorption
related duodenal enzymes, such as duodenal cytochrome
B (Dcyt1b) and hephaestin, could affect iron deficiency in
obesity. Other studies have reported that inflammatory
markers, tumor necrosis factor alpha (TNF-α) and inter-
feron gamma (IFN-γ), directly disturbed iron absorption
into the enterocyte [4, 19–21].
Excess adiposity leads to chronic inflammatory responses
by increasing macrophage infiltration into adipocytes.
Growing evidence suggests that inflammation is one of the
main contributors to iron deficiency [22, 23]. Calorie re-
striction has been reported to ameliorate inflammation
through suppressing inflammatory cytokines. Monocyte
chemoattractant protein 1 (Mcp-1), Il-6 and Tnf-α mRNA
and CRP protein levels in adipose tissue were lowered in
rodents with 30% or more calorie restriction compared
with those fed ad libitum [24, 25]. However, iron status
was not measured in these calorie restricted animals. If
chronic inflammation caused by excess adiposity is linked
to iron deficiency, calorie restriction may have the potential
to change iron status. Therefore, studies are required to
examine whether alleviation of inflammation and further
reduction of body weight achieved by calorie restriction
has an impact on iron status.
This study compared hepatic iron levels using mildly
calorie restricted, obese, and control mice to clarify the
relationship between adiposity and iron status. To under-
stand the mechanism responsible for differences in iron
storage associated with body adiposity, the levels of
hepcidin, pro-inflammatory markers, and duodenal en-
zymes involved in iron transport were determined.
Methods
Animals and diets
Male C57BL/6 N mice (7 weeks old) were purchased from
Central laboratory Inc. (Seoul, Korea) and individually
housed in the specific pathogen free (SPF) animal facility
at Seoul National University. After 1 week of acclimation
with the control diet, mice were assigned to one of 3
dietary groups and fed experimental diets for 16 weeks:
calorie restriction (CR, n = 16), control (Control, n = 24),
and high fat (HFD, n = 25) diets. The Control group was
fed the control diet (10% energy from fat, Research Diets,
New Brunswick, NJ, USA, #D12450B) ad libitum and CR
group was fed a reduced amount of control diet to achieve
15% calorie restriction. The HFD group was fed with a
high fat diet (60% energy from fat, Research Diets,
#D12492) ad libitum. After 16 weeks, mice were fasted for
12 h and euthanized by CO2 asphyxiation. Blood, liver,
duodenum and white adipose tissue were collected and
samples were stored at -80 °C.
Determination of liver non-heme iron content
Hepatic non-heme iron levels were measured using the
colorimetric method as previously described by Brain et al.
[26]. Liver samples (100 mg) were homogenized and
hydrolyzed in 2 ml of acidic solution (mixture of 3 mol/L
HCl and 10% trichloroacetic acid). After 20 h incubation,
supernatant was collected and mixed with chromogen re-
agent containing bathophenanthroline sulfonate. After
10 min incubation, absorbance was measured at 535 nm.
Iron concentration was expressed as microgram of iron
per gram of wet tissue.
Determination of liver protein oxidation
Hepatic protein oxidation was determined using the
Oxyblot™ Protein Oxidation Detection kit (S7150; Millipore,
Billerica, MA, USA) based on Western blot analysis. Pro-
tein oxidation was detected by measuring carbonyl groups
in the protein side chain derived from the oxygen free
radicals. Briefly, liver protein was extracted and derivatized
to 2, 4-dinitrophenylhydrazone (DNP-hydrazone), sepa-
rated by SDS-PAGE, then transferred onto PVDF mem-
brane. Membranes were incubated with rabbit anti-DNP
(1:150) to detect DNPH-derivatized proteins, washed, then
incubated with goat anti-rabbit IgG (1:300). After the
reaction with chemiluminescent reagent, DNPH derivatized
proteins were detected and analyzed using a mixture of
standard proteins as the loading control.
RNA preparation and real time PCR
RNA was extracted using TRIZOL reagent (Invitrogen,
CA, USA) from liver and duodenum. Reverse transcrip-
tion was performed using the PrimeScript™ 1st strand
cDNA synthesis kit (Takara bio Inc., Japan). mRNA
levels of Hamp, Mcp-1, Tnf-α in liver, Fpn, Dmt1, Dcyt1b,
and Heph in duodenum were determined by real-time
PCR with a SYBR Premix Ex Taq (Takara bio Inc.) and
StepOne Real-time PCR System (Applied Biosystems,
CA, USA). The relative expression of each gene was
calculated from 2-ΔΔCT. All values were normalized to
the levels of Gapdh and expressed as relative mRNA
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level compared to the average level of the Control
group.
Western blot analysis
Protein was isolated from liver tissue using RIPA lysis buf-
fer and protein concentration was determined by Bradford
assay (Bio-Rad Laboratories, CA, USA). Fourty μl of
protein was separated by electrophoresis on a 10%
SDS-polyacrylamide gel. Separated proteins were blot-
ted onto a PVDF membrane and blocked in Tris buff-
ered saline/0.1% Tween-20 (TBST, pH 7.6), containing
5% skim milk. Membrane was incubated with sheep
anti-human ferritin (The Binding site Ltd., Birmingham,
UK), washed, then incubated with HRP-conjugated
donkey anti-sheep IgG (Santa Cruz, CA, USA). Membrane
bound antibodies were visualized with enhanced chemilu-
minescence (ECL) solution (Santa Cruz). Band density
was analyzed using QuantityOne software (Bio-Rad
Laboratories) with β-actin as the loading control.
Statistical analysis
One-way analysis of variance (ANOVA) was used to de-
termine overall differences among groups, followed by
Fisher’s least significant difference (LSD) test for individ-
ual group comparisons. Pearson’s correlation was used
to determine the association between parameters. The
results from all comparisons were considered significant
at P < 0.05. Data were reported as mean ± SEM. All data
were analyzed using the SPSS 21.0 program (SPSS Inc.,
IL, USA).
Results
Body weight and adipose tissue weight
After 16 weeks of feeding, body weights were significantly
different among groups (P < 0.001). Body weight of the
HFD group (48.80 ± 0.49 g) was higher than those of the
Control (37.08 ± 0.56 g) and CR (27.53 ± 0.76 g) groups,
and the CR group had lower body weight than the Control
group. White adipose tissue weight was lower in the CR
group than the Control (55% lower, P < 0.001) and HFD
(74% lower, P < 0.001) groups, and it was lower in the
Control group than the HFD group (43% lower, P < 0.001).
Liver weight per body weight (g liver weight/100 g body
weight) was also different among groups, and significantly
lower in the CR group compared with the Control (P <
0.01) and HFD (P < 0.001) groups (Table 1).
Serum hemoglobin and hematocrit levels
Hemoglobin and hematocrit levels were not different
among groups (Table 2).
Liver non-heme iron concentrations and ferritin protein
levels
Hepatic non-heme iron concentrations were significantly
different among groups (P < 0.001). The CR group had
significantly higher non-heme iron level (291. 20 ±
26.48 μg/g tissue) compared with the Control (136.21 ±
16.99 μg/g tissue) and HFD (89. 92 ± 9.52 μg/g tissue)
groups (Fig. 1a). Hepatic ferritin protein levels were higher
in the CR group than the Control (70% higher, P < 0.001)
and HFD (207% higher, P < 0.001) groups. The HFD
group’s ferritin level was significantly lower than that of
the Control group (45% lower, P < 0.001) (Fig. 1b). Hepatic
non-heme iron levels correlated negatively with white
adipose tissue weights (r = -0.689, P < 0.001), and body
weights (r = -0.711, P < 0.001) (Fig. 2a). Hepatic ferritin
protein levels also showed negative correlations with
white adipose tissue amount (r = -0.740, P < 0.001), and
body weights (r = -0.708, P < 0.001) (Fig. 2b).
Hepcidin (Hamp) and bone morphogenic protein (Bmp6)
mRNA levels in liver
Hepatic Hamp mRNA levels were significantly different
among groups. The CR group had higher Hamp mRNA
levels than the Control (95% higher) and HFD (242%
higher) groups and the Control group had higher mRNA
levels than the HFD group (76% higher, P = 0.073) (Fig. 3a).
The mRNA levels of Bmp6 which regulates hepcidin
expression were higher in the CR group compared with
the Control (206% higher) and HFD (151% higher) groups.
There was no significant difference in Bmp6 mRNA levels
between Control and HFD groups (Fig. 3a). Hepatic
Table 1 Body weight and weight gain of mice in the CR, Control, and HFD groups1
CR (n =16) Control (n = 24) HFD (n = 25) P value
Body weight at 0 week (g) 22.68 ± 0.20 22.40 ± 0.22 22.26 ± 0.21 0.44
Body weight at 16 week (g) 27.53 ± 0.76a 37.08 ± 0.56b 48.80 ± 0.49c <0.001
Body weight gain (g) 4.8 ± 0.8a 14.7 ± 0.5b 26.5 ± 0.5c <0.001
Daily calorie intake (kcal/day) 11.43 ± 0.16a 13.49 ± 0.14b 15.59 ± 0.15c <0.001
White adipose tissue (g) 2 1.76 ± 0.14a 3.94 ± 0.15b 6.87 ± 0.11c <0.001
Liver weight per body weight
(g/100 g body weight)
4.18 ± 0.15a 5.11 ± 0.11b 5.58 ± 0.23b <0.001
1One-way ANOVA followed by Fisher’s LSD multiple comparison was used to determine significant differences
2White adipose tissue weight included epididymal, subcutaneous, retroperitoneum, and perinephric fat
abcDifferent superscript letters indicate significant differences at P < 0.05
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Hamp and Bmp6 mRNA levels showed positive correla-
tions with non-heme iron levels (Hamp: r = 0.600, P <
0.001; Bmp6: r = 0.707, P < 0.001, data not shown). On
the other hand, negative correlations were observed be-
tween white adipose tissue weights and hepatic Hamp
and Bmp6 mRNA levels (Hamp: r = -0.567, P < 0.001;
Bmp6: r = -0.559, P < 0.01, data not shown).
Pro-inflammatory cytokines mRNA levels in liver
Figure 3b shows hepatic Mcp-1 and Tnf-a mRNA levels.
Mcp-1 mRNA levels were lower in the CR group com-
pared with other two groups (63% lower than Control,
P < 0.05 and 74% lower than HFD, P < 0.001). Tnf-a
mRNA levels were lower in the CR group than the HFD
group (47% lower, P < 0.05). The mRNA levels of Mcp-1
and Tnf-a negatively correlated with liver iron concentra-
tion (r = -0.557, P < 0.01; r = -0.464, P < 0.05, respectively)
(Fig. 2c and d).
Oxidation status of proteins in liver
Hepatic protein oxidation levels were not significantly
different among groups (Fig. 4).
Iron transporters, oxidoreductases and ferritin mRNA
levels in duodenum
To investigate whether HFD induced obesity and calorie
restriction affected iron absorption, mRNA levels of
duodenal enzymes involved in iron transport, divalent
metal transporter1 (Dmt1), ferroportin (Fpn), duodenum
cytochrome 1b (Dcyt1b), and hephaestin (Heph) were
measured (Fig. 5). mRNA levels of Dmt1 and Fpn were
not significantly different among groups. However, oxi-
doreductase Dcyt1b expression was significantly higher
in the CR (229% higher) and Control (204% higher)
groups compared with the HFD group. Heph expression
was significantly higher in the CR (85% higher) and HFD
(63% higher) groups compared with the Control group.
There was no significant difference in duodenal ferritin
(Fth1) mRNA levels among groups.
Discussion
The present showed that liver iron levels were inversely
associated with body weights and white adipose tissue
amount. The study showed not only that hepatic iron
storage was lower in the HFD group, which is consistent
with previous findings [3], but also that lower body weight
achieved by mild calorie restriction resulted in higher
non-heme iron concentration and hepatic ferritin protein
level in comparison with Control animals. Inflammation
in hepatic milieu and levels of duodenal oxidoreductases
appear to be involved in the adiposity related differences
in liver iron status.
To achieve mild calorie restriction, the CR group
were fed 15% reduced amount of control diet without
Table 2 Levels of hemoglobin and hematocrit of mice in the CR, Control, and HFD groups1
CR (n =16) Control (n = 24) HFD (n = 25) P value
Hemoglobin (g/dl) 14.66 ± 0.21 14.42 ± 0.13 14.28 ± 0.21 0.409
Hematocrit (%) 49.31 ± 1.12a 47.01 ± 0.92b 46.92 ± 0.56c 0.124
1One-way ANOVA followed by Fisher’s LSD multiple comparison was used to determine significant differences
abcDifferent superscript letters indicate significant differences at P < 0.05
Fig. 1 Liver non-heme iron concentration and ferritin protein
level: a Liver non-heme iron level per gram of tissue (μg/g tissue);
b Densitometric analysis of liver ferritin protein expression and
representative ferritin Western blots. The intensity of ferritin was
densitometrically measured and normalized to the protein expression
level of β-actin. abcDifferent superscript letters indicate P< 0.05. One-way
ANOVA followed by Fisher’s LSD multiple comparison was used to
determine significant difference. n = 16–25 per group
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additional supplements. Iron levels of the experimental
diets were 35 mg Fe/kg in the control diet, the NRC
suggested requirement for iron [27], and 48 mg Fe/kg
in the high fat diet. Considering daily diet intake of
each group, actual average iron intake was 104 μg Fe/day
in the CR group, 15% lower than that in the Control
group (123 μg Fe/day). Sorbie and Valberg [28] reported
that diets containing 25–100 mg Fe/kg diet could support
normal growth and hematopoiesis of C57BL/6 J mice.
Therefore, a 15% decrease in dietary iron intake is unlikely
to affect normal growth and metabolism.
Despite a lower dietary iron intake, hepatic non-heme
iron levels were 114% higher and ferritin protein levels
were 60% higher in the CR group compared with the
Control group. On the other hand, the HFD group
showed 34% lower non-heme iron levels and 45% lower
ferritin protein levels compared with the Control group,
although their iron intake was 16% higher than the Con-
trol group. Human and animal studies have also reported
reduced iron status with obesity [3, 4, 29]. Restoration of
serum iron and hemoglobin levels after weight loss in
obese people has been observed in several studies, which
suggest an association between adiposity and iron status
[30, 31]. Higher iron status in very lean mice from the CR
group compared with the control animals further supports
the close association between adiposity and iron levels.
Obesity could lead to chronic inflammation and oxi-
dative stress; due to macrophage recruitment into adi-
pose tissue and release of pro-inflammatory cytokines
through various signals. Reactive oxygen species (ROS)
production is also increased by these cytokines and
overconsumption of oxygen during obesity [32–34]. On
the other hand, calorie restriction has been reported to
alleviate inflammation and ROS production [24, 35, 36].
In this study, mRNA levels of Tnf-α and Mcp-1 showed
positive correlations with white adipose tissue amount,
and expression of these cytokines were significantly
higher in the HFD group than the CR group. However,
degrees of oxidative stress, examined by determination
of protein oxidative carbonyl content, were not signifi-
cantly different among the groups. According to the
review by Dixon et al. [37], iron and iron derivatives
were essential for ROS producing enzyme function and
they contributed to formation of ROS. Higher non-heme
iron and ferritin levels in the CR group could have led to
higher redox-active iron pools which would contribute to
Fig. 2 Correlations between liver iron levels and white adipose tissue or hepatic inflammatory markers: a Liver non-heme iron level (μg/g tissue)
and white adipose tissue weight (g), n = 63; b Liver ferritin protein level and white adipose tissue weight (g), n = 63; c Hepatic Mcp-1 mRNA level
and non-heme iron level (μg/g tissue), n = 21; d Hepatic Tnf-α mRNA level and non-heme iron level (μg/g tissue), n = 21; Pearson correlation
coefficient, r, and P value are indicated for each graph
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the ROS formation. Therefore, lower inflammation in the
CR group did not result in significant reduction of oxida-
tive stress.
Not only hepatic iron concentration but also hepatic
ferritin protein levels, which are both involved in iron
storage, showed negative correlations with hepatic
Mcp-1 and Tnf-α levels. TNF-α has been reported to in-
duce hypoferremia by inhibiting iron absorption through
the small intestine in mice [20, 38]. Mcp-1 has been re-
ported as a TNF-α induced gene [39]. Although the mech-
anism has not been explicitly elucidated, Laftah et al. [38]
reported that mucosal transfer of iron was reduced in
TNF-α treated mice and was associated with increased
level of duodenal ferritin that could trap ferric iron within
the enterocyte. In this study, although not statistically sig-
nificant (P = 0.102), mean duodenal Fth1 mRNA level was
higher in the HFD group compared with the Control and
CR groups, which was opposite to the case of ferritin pro-
tein levels in liver. In this regard, increased Tnf-α and
Mcp-1 expression could be responsible for decreased iron
absorption throughout the enterocyte.
Many previous studies that reported iron deficiency
with obesity suggested that hepcidin was responsible for
obesity driven iron shortage and hepcidin was upregulated
by inflammatory signals [9]. However, in the present
study, the mRNA levels of Hamp and Bmp6 were lowest
in the HFD group and highest in the CR group. Hepcidin
is the main regulator of systemic iron homeostasis by re-
ducing total iron content and its expression is regulated
by Bmp6 [12, 17]. Hepcidin synthesis is increased by
excess iron levels or inflammatory signals and de-
creased by iron deficiency, hypoxia, or erythroid [40].
Darshan et al. [14] showed that inflammation induced
by LPS increased Hamp expression in normal mice,
while this mechanism was blunted in LPS stimulated
mice with iron deficiency, as their Hamp levels were
decreased. They concluded that severe iron deficiency
Fig. 3 Relative hepatic mRNA levels of genes involved in iron
homeostasis and inflammation: a Heph (n = 16–23 per group) and
Bmp6 (n = 7 per group) mRNA levels; b Mcp-1 and Tnf-a. mRNA
levels (n = 7 per group). Data are presented as mean ± SEM.
abDifferent letters indicate P < 0.05. One-way ANOVA followed by
Fisher’s LSD multiple comparison was used to determine significant
difference. All values were normalized to the levels of housekeeping
gene Gapdh and expressed as relative mRNA level compared to the
average level of the Control group
Fig. 4 The oxidation status of liver proteins: a Densitometric analysis of protein carbonyls; b Representative Western blots for protein carbonyls in
the four lines of standard protein and liver protein in CR, Control, and HFD groups. The intensity of protein carbonyls was densitometrically measured
and normalized by the level of standard protein. Data are presented as mean ± SEM, n = 7 for each group. One-way ANOVA followed by Fisher’s LSD
multiple comparison was used to determine significant difference
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could ameliorate hepcidin expression in response to
LPS. In this study, although Mcp-1 and Tnf-α mRNA
levels were higher in the HFD group, indicative of
increased inflammatory response, hepcidin levels were
lower than the other groups. Lower iron levels in the
HFD group could have overridden the effect of these
inflammatory mediators on hepcidin expression. Thus,
hepcidin levels seemed to be mainly regulated by bodily
requirements for iron in this study.
Expression of iron absorption related enzymes in
duodenum tissue was determined to investigate the asso-
ciation between adiposity and iron status. mRNA levels
of Dcyt1b and Heph, which is located at both sides of
enterocyte and facilitate iron transport, were highest in
the CR group. Dcyt1b is the ferric reductase that
converts ferric iron to the ferrous state that enables iron
to enter the apical side of enterocyte through the Dmt1,
and hephaestin is the ferroxidase at the basolateral side of
the enterocyte [41, 42]. Calorie restriction could have
promoted iron absorption by upregulating those duodenal
enzymes that enable the physical state of iron to enter the
enterocyte. Sonnweber et al. [19] reported lowered Dcyt1b
and Heph mRNA levels in obese mice compared with
control mice. They suggested that decreased levels of
ferroxidases were associated with iron deficiency in
obesity. In this study, Dcyt1b expression was lowest in
the HFD group and it showed significant negative cor-
relation with white adipose tissue amount (r = -0.509),
however, hephaestin level was upregulated in the HFD
group compared with the Control group. Considering that
hephaestin is affected by stored iron amount rather than
by instant dietary iron intake [41], low iron status in the
HFD group could have influenced Heph expression and
led to higher expression in the HFD group. However,
further research is needed to identify the relationship
between adiposity and duodenal iron absorption and to
find obesity related factors that regulate expression of iron
transport enzymes.
Conclusions
This study confirmed that liver iron status has an inverse
relationship with body adiposity. More importantly, we
showed that liver iron levels could be upregulated in low
adiposity through mild calorie restriction. Low inflam-
matory state induced by calorie restriction could be
responsible for higher hepatic iron storage. Upregulated
duodenal iron transport enzymes appeared to contribute
to higher hepatic iron levels in the CR group.
Fig. 5 Relative duodenal mRNA levels of ferritin and enzymes involved in iron transport: a Dmt1, Fpt(ferroportin), Heph(hephaestin), and Dcyt1b
mRNA levels; b Fth1(ferritin) mRNA levels. Data are presented as mean ± SEM, n = 7–12 for each group. abDifferent letters indicate P < 0.05. One-way
ANOVA followed by Fisher’s LSD multiple comparison was used to determine significant difference. All values were normalized to the levels of
housekeeping gene Gapdh and expressed as relative mRNA level compared to the average level of the Control group
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